| Identification | Back Directory | [Name]
3-Azabicyclo[3.1.0]hexane-2-carboxamide, N-[(1S)-1-cyano-2-[(3S)-2-oxo-3-pyrrolidinyl]ethyl]-3-[(2S)-3,3-di(methyl-d3)-1-oxo-2-[(2,2,2-trifluoroacetyl)amino]butyl-4,4,4-d3]-6,6-dimethyl-, (1R,2S,5S)- | [CAS]
2861202-76-6 | [Synonyms]
3-Azabicyclo[3.1.0]hexane-2-carboxamide, N-[(1S)-1-cyano-2-[(3S)-2-oxo-3-pyrrolidinyl]ethyl]-3-[(2S)-3,3-di(methyl-d3)-1-oxo-2-[(2,2,2-trifluoroacetyl)amino]butyl-4,4,4-d3]-6,6-dimethyl-, (1R,2S,5S)- |
| Hazard Information | Back Directory | [Uses]
Nirmatrelvir-d9 (PF-07321332-d9) is the deuterium labeled Nirmatrelvir (HY-138687)[1]. | [References]
[1] Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-223. DOI:10.1080/02688697.2018.1500521 |
|
|